[Influence of polymorphisms of VEGFR2 on clinical outcomes and safety of advanced non-small-cell lung cancer treated by first line Bevacizumab plus chemotherapy regimens]

Subjects

Subjects :

Bevacizumab
Lung Neoplasms
Polymorphism, Genetic
Treatment Outcome
Genotype
Carcinoma, Non-Small-Cell Lung
Antineoplastic Combined Chemotherapy Protocols
Humans
Polymorphism, Single Nucleotide
Vascular Endothelial Growth Factor Receptor-2

Details

ISSN :

03762491

Volume :

99

Issue :

2

Database :

OpenAIRE

Journal :

Zhonghua yi xue za zhi

Accession number :

edsair.pmid..........c5867a9149af6467477ddb4d50a6b144